Twenty-five years after she helped launch the original Nicktoons, Linda Simensky is still deciding what millions of kids watch on TV—and teaching Penn students who grew up loving the shows she developed.
The author wanted to know why the stem-cell treatments that worked so well for her hobbled dog aren’t being used to put the spring back in humans’ steps. Researchers at Penn’s Institute for Regenerative Medicine explained—and shared some of their own, measured, progress toward successful therapies.
With an innovation portfolio that ranges from medical devices to folding bicycles to social-impact enterprises to junk food, Wharton professor Karl Ulrich has every justification to bask in entrepreneurial mystique. Only that’s exactly what he sets out to demolish in the classroom.